Introduction
Enterotoxigenic Escherichia coli (ETEC) is a bacterial pathogen responsible for severe diarrhoea diseases in animals and humans. Enterotoxigenic Escherichia coli leads to high morbidity and mortality both for neonatal and post-weaning pigs (Harvey et al., 2006) . ETEC diarrhoea causes slow growth, weight loss and death, which result in considerable economic losses for hog producers worldwide (Trevisi et al., 2015) . The major virulence factors of these bacteria are bacterial fimbriae/non-fimbrial adhesins and enterotoxins (Nataro and Kaper, 1998) . Fimbriae/non-fimbrial adhesions mediate the attachment of bacteria to host intestinal villus and facilitate bacterial colonization. Then, signal peptide guides enterotoxins through the cell membrane, and causes epithelial cell chloride-ion secretion and preventing sodium chloride absorption, exacerbated secretory diarrhoea by simultaneous fluid movement into the lumen (Field et al., 1978) . In the past decade, ETEC infection has been prevented using antibiotic agents (Smith et al., 2010) . Recently, multi-resistance has been reported with increasing frequency in several countries worldwide, as hogs have frequently been treated as a group with excessive mass medication (Wang et al., 2010) . Moreover, antibiotics could select resistant Escherichia coli to transfer their resistance plasmids to other bacteria that may include pathogens in the faecal flora (Nijsten et al., 1996) . Thus, the objective of this study is the prevention of ETEC invasion by alternative methods (Bischoff et al., 2002) . Immunization remains an effective approach for preventing infectious diseases. However, there is no broadly effective vaccine available for swine ETEC diarrhoea in China. An effective porcine ETEC vaccine should include all the enterotoxins antigens to lead to anti-heat-labile enterotoxin (anti-LT) and anti-heat-stable enterotoxins (antiSTa and anti-STb) immunity .
Recent studies showed that most commercial vaccines are administered by injection, stress response in newborn piglets is induced by repeated injection. Nevertheless, activation of secreted intestinal anti-ETEC responses is impossible to achieve by parenteral administration (Lasaro et al., 2005) . Therefore, stimulating a protective immune response by colonization in the intestinal mucosa without causing inflammations is important for an ETEC vaccine. The gastrointestinal tract (GIT) is the animal's largest immunological organ, with a daily production of more than 60% of antibodies (Tang and Li, 2009) . Mucosal immune activity plays a major role in neutralizing ETEC upon entry into the body (Kotton and Hohmann, 2004) . Oral vaccination avoids the use of syringes, which evokes both local and systemic immune responses, and production of secreted immunoglobulin A (IgA) blocks bacterial attachment to the intestinal epithelial cells (Jertborn et al., 1998) . Furthermore, attenuated strains express more heterologous antigens simultaneously, and safely deliver multiple expressed antigens at mucosal sites (Charles and Dougan, 1990) . In addition, oral bacterial vaccine vectors are stable in storage, simple to administer and inexpensive to manufacture (Ascon et al., 1998) .
In this study, we have established a recombinant E. coli strain in pseudogene positions yaiT expressing LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb fusion immunogen. Using an oral vaccine, we have gained detailed insight into the immune responses in mouse models. The statistics show that oral immunization with ER-T can elicit more potent systemic and mucosal immune response in mice.
Results

Establish double selection platform and assess its performance
PCR was used to identify O142 (yaiT-Kil) using primers T1 and T4. The products showed that the E. coli O142: DSTa (yaiT gene, 800 bp), O142:MSTa/pKil-donor (yaiT gene, 800 bp; pKil-donor, 3800 bp) and O142 (yaiT-Kil) (yaiT with Kil cassette flanked, 3800 bp) were of expected size (Fig. 1, panel B) . The double selection platforms were plated on MacConkey agar 18 h later, the platform strains grew normally at 30°C. Platform-expressed Kil gene caused cells to die at 43°C (Fig. 1, panel C) .
Expression of the fusion protein by recombinant E. coli ER-T was verified by PCR using the primers T1 with P2. The product of ER-T was of expected size (3000 bp) for LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb fusion gene, meanwhile, there were no bands in O142:MSTa, O142 Fig. 1 . The schematic outline of the recombinant strategy for constructing the double selection platform. Panel A. Construction of the double selection platform O142(yaiT::PRPL-Kil) by homologous recombination. The pKil-donor plasmid and the pACBSCE plasmid are co-transformed into the Attenuated E. coli O142:MSTa. L-arabinose induction promotes expression of the I-SceI recombinase system and the k-Red endonuclease. I-SceI generates a linear DNA fragment from the pKil-donor plasmid that is a substrate for recombination with the pseudogene mediated by the k-Red system. Panel B. PCR analysis of chromosomal DNA from double selection platform O142(yaiT::PRPL-Kil) by using the primers T1 and T4. N: PCR negative control; M: molecular size marker; 1: PCR product of E. coli O142: MSTa; 2: PCR product of O142: MSTa/pKil-donor; 3: PCR product of O142(yaiT::PRPL-Kil). Panel C. Inversion screen test of the double selection platform. a: O142(yaiT::PRPL-Kil) incubated at 43°C, cannot grow on MacConkey agar plates; b: O142(yaiT::PRPL-Kil) incubated at 30°C, grown normally. (yaiT-Kil) (Fig. 2, panel C) . After sequencing, we found that fusion genes (LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb cassette) were correct insertions of the E. coli O142:MSTa (data not shown). In addition, Western blot analysis of LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb fusion protein, and the expected sizes (17 kDa and 35 kDa) were observed (Fig. 2, panel D) .
Feasibility analysis
Mice were orally inoculated with ER-T, after 4 h gut/carcass mass ratios (G/C = 0.065 AE 0.006) remained normal, E. coli O142 and E. coli 344-C induced a significant increase of intestinal fluid accumulation in mice model (G/ C = 0.125 AE 0.005, G/C = 0.107 AE 0.003), indicating that Fig. 2 . The schematic outline of the recombinant strategy for constructing the recombinant E. coli O142(yaiT::LTA1-STa13-STb-LTA2-LTBSTa13-STb) for oral vaccine candidate. Panel A. The full-length porcine LT192 operon was used conjugate with LT192, STa13, STb for generating LTA1-STa13-STb-LTA2-LTBSTa13-STb fusion antigen and the native LT promoter was retained which expressed without induction. PCR primers P1 and P2 amplified the entire LT cassette including the native LT promoter and terminator. Primers P2 paired with P4 amplified the STa13-6 9 His-terminator chimeric gene. Primers A1 and A7 mutated the LT gene for LT192. Panel B. Construction of the recombinant E. coli O142(yaiT::LTA1-STa13-STb-LTA2-LTB-STa13-STb) according to Gene Doctoring method. The pL-S-donor plasmid and the recombineering plasmid pACBSCE are co-transformed into the double selection platform. Arabinose induction promotes expression of the k-Red gene products and I-SceI. I-SceI cleaves the pL-S-donor plasmid resulting in generation of the linear DNA fragment for k-Red mediated recombination to generate the recombinant E. coli O142(yaiT:: LTA1-STa13-STb-LTA2-LTB-STa13-STb). Panel C. PCR reaction for the verifying of the recombinant E. coli strain ER-T by using the primers yaiT-L-arm and P2. M: molecular size marker; N: PCR negative control; 1: PCR product of E. coli O142: MSTa; 2: PCR product of O142(yaiT::PRPL-Kil); 3: PCR product of ER-T. Panel D. Detection of the LTA1-STa13-STb-LTA2-LTB-STa13-STb fusion protein in the Western blot assay. anti-His (ZSGB-BIO Co.; 1:500) were used as primary antibody and secondary antibody by (HRP)-conjugated goat anti-mouse IgG (ZSGB-BIO Co.; 1:2000), development following the manufacturer's instructions of ECL Plus Reagent Kit (7 Sea Biotech, China) M: Protein marker; 1: E. coli O142: MSTa as the negative control; 2: E. coli ER-T.
the toxicity of ER-T had been reduced or eliminated (Fig. 3, panel A) . The results of in vitro cytotoxicity assay showed that supernatant of ER-T cannot cause ZYM-DIEC02 cells to die, but supernatant of E. coli O142 (STa), 274-A (LT) and 344-C (STb) induce cell death (Fig. 3,  panel B) . The tolerance test indicated that ER-T tolerates well gastric acid pH 2.5 to 4.5, intestinal juice, and bile 0.05-0.3% (Fig. 3, panels C-E) . During the first 3 days of the rearing period, the feed intake decrease. Over the whole period, the feed intake and weight were similar in each group (Fig. 3, panel F) . The stability curves of ER-T in the growth phases were similar and no significant differences between them were found, indicating that insertion of the chimeric gene did not impact the growth of the bacterial cell (Fig. 3, panel G) . Large doses of ER-T did not affect the weight gain of mice (Fig. 3, panel H) . We checked the stability of ER-T, and the results indicated that all the colonies analysed presented the expected bands. Sequencing showed that chimeric gene LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb is not lost after 100 generations (data not shown). EM images revealed that insertion of the LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb fusion gene did not affect the E. coli O142: DSTa fimbriae expression (Fig. 3, panel I ). The colonization assay demonstrated that ER-T had a higher binding capacity in the intestinal tract of mice (Fig. 3, 
panel J).
Systemic and mucosal immunogenicity elicited by recombinant E. coli After oral immunization recombinant, bacteria can enhance the serum IgG and faecal IgA. High levels of anti-F41, anti-LTA, anti-LTB, anti-STa and anti-STb IgG antibodies were detected after 7, 14, 14, 21 and 21 days in the serum samples respectively (Fig. 4A-E) . Forty-two days after immunization, ER-T (Fig. 4F-I ) specific IgG antibodies were revealed in milk, spleens, mesenteric lymph nodes and intestinal mucus samples. By contrast, in the control groups there was no enhancement of specific IgG antibody responses. Similar findings were revealed on the secreted IgA antibody responses in faeces of mice after being administered orally with ER-T (Fig. 5A-I ). These results show that the recombinant E. coli has the capability to elicit both systemic and mucosal antibody responses.
Lymphocyte proliferation responses and cytokines assay
The results indicated that the splenic and mesenteric lymphocytes from mice immunized orally with ER-T showed significant responses compared with the PBS group by an MTT assay. For splenic lymphocyte proliferation, splenocyte, mesenteric lymphocyte from different groups of immunized mice were cultured in vitro. The higher level of proliferation was demonstrated in ER-T group for STa, LT 192 -STa 13 , STb, LT 192 -STb, LT with the mean SI of 2.38, 2.34, 2.40, 2.11 and 2.31 (Fig. 6, panel  A) . In addition, the group of ER-T (Fig. 6, Mice vaccinated with ER-T had splenic lymphocytes IFN-c (mean 43.55 AE 12.63), and neither were different from those found in splenic lymphocytes from both control groups (Fig. 6, panel C) . In contrast, the groups vaccinated with ER-T (mean 313.89 AE 33.21) had notably higher splenic lymphocytes IL-4 than the groups control (Fig. 6, panel D) . When the IL-4 to IFN-c ratio was analysed, it was found that the oral immunization groups had 7 times more IL-4 than IFN-c, which is a clear indicator of a polarized Th2 immune response.
Toxin-neutralizing ability in vitro
We used ZYM-DIEC02 cells to detect the neutralizing efficacy of serum, intestinal mucus, splenocyte lysate and mesenteric lymphocyte lysate from orally inoculated mice. Results showed that the samples (from the immunized mice) had effective neutralization LT toxin, in serum (1:32), splenocyte lysate (1:16), intestinal mucus (1:32) and mesenteric lymphocytes lysate (1:32) (Fig. 7 , the samples from the immunized mice group of ER-T showed the neutralization ability to STb toxin in serum of (1:2.5), splenocyte lysate (1:7.5), intestinal mucus (1:2.5) and mesenteric lymphocyte lysate (1:2.5) (Fig. 8 , panel E-H).
Protection efficacy of maternal antibody
The protective efficacy of suckling mice intaking milk from the immunized pregnant mice challenged with STa or STb toxin was investigated. After being administered orally with STa toxin (1:15 diluted) the ER-T G/ C ratios, outlined below (ER-T G/C = 0.083 AE 0.005), significantly below that of the mice of the control group (Fig. 9, panel A) . Likewise, after challenge with STb toxin (1:15 diluted), ER-T G/C ratios outlined below (ER-T G/C = 0.080 AE 0.005), which is lower than control (1:15 diluted G/C = 0.104 AE 0.005) and O142:M STa (1:15 diluted G/C = 0.094 AE 0.006) (Fig. 9, panel  B) . 
Discussion
Porcine ETEC-associated diarrhoea, especially PWD and neonatal piglet diarrhoea, remains a major problem for swine producers around the world, but an effective vaccine against neonatal piglet diarrhoea and PWD is lacking (Ruan and Zhang, 2013) . Due to the vast majority of piglet diarrhoea being caused by ETEC expressing K88ac or F18 fimbriae in North America (Zhang et al., 2007) , abundantly expressed CFA/I, 987P, K99, F18 and/or K88ac fimbriae vaccines were developed. However, in China, pregnant sows are often vaccinated with inactivated vaccines containing fimbriae antigens to protect their offspring from intestinal infection with ETEC. In a recent epidemiological survey, the fimbriae were not frequently associated with ETEC for suckling pigs with diarrhoea in China. Likewise, low proportions of adhesinpositive E. coli strains have been reported in previous studies in the Netherlands (Guinee and Jansen, 1979) , Japan (Nakazawa et al., 1987) and Sweden (Soderlind et al., 1988) . Therefore, efficient ETEC vaccines should work against enterotoxins (Ruan and Zhang, 2013) . Oral subunit or killed vaccine antigen delivery through the digestive tract is subject to digestive degradation. Therefore, oral vaccination must maintain the integrity of the antigen during delivery to the intestinal tract. Recently, extensive work on a live vehicle vaccine system presented evidence that recombinant attenuated E. coli is an efficient carrier for antigens by the oral route . In our study, we build oral vaccine strains obtained from attenuated wild-type ETEC strain. Moreover, recombinant bacteria achieve ephemeral colonization in the host by F41 fimbriae to overcome host defences, such as the gastrointestinal mucus barrier and intestinal peristalsis cleaning mechanism (Pacheco et al., 2012) . Orally administered ER-T can deliver antigens to the immune system for a prolonged period. In addition, we demonstrated that a single oral dose of recombinant E. coli was without significant reactogenicity or toxicity at dosages up to 10 9 CFU. Recombinant E. coli containing LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb operon have been stably maintained for over 100 generations in wild-type E. coli. Another aspect of this research is that it is the first report of oral polyvalent vaccine fusion of all swine ETEC enterotoxins simultaneously. Enterotoxins are an important virulence factor of swine ETEC strains and have been frequently identified in pigs with ETEC diarrhoea disease (Zhang et al., 2006) . The most significant contributors to piglet ETEC diarrhoea were LT, STa and STb. STa is composed of only 19 amino acids (2 KDa), so the immunogenicity is poor, and it can cause diarrhoea unless inactivated or modified STa peptides pSTa (A13Q) reduction toxicity . Recent studies indicate that STa (A13Q) fuses to LT became immunogenic , resulting in LT-STb fusion antigen can stimulate body to produce antibodies against LT and STa toxins . STb positive isolates from diarrhoeic piglets were more prevalent than STa in Canada (Harel et al., 1991) , Poland (Osek and Truszczynski, 1992) and Spain (Blanco et al., 1997) respectively. STb consisting of 40 amino acids (5.2 KDa) was too short for induced antiSTb immunity in hosts (Sears and Kaper, 1996) . Moreover, a study demonstrated that STb coupled to an appropriate carrier molecule had the advantages of reducing toxicity and inducing neutralizing antibodies (Dubreuil et al., 1996) .
LT consisted of a toxic A1 subunit (LTA1), non-toxic A2 subunit (LTA2) and five identical polypeptide chains of B subunit (LTB) (Spangler, 1992) and was capable of enhancing systemic and mucosal antibodies. Insertion of exogenous genes between LTA1 and LTA2 shows that reduce the toxicity of LTA1 and preserve the adjuvant function of LTA (Zhang and Sack, 2015) . LTB is a potent immunogen and possess adjuvant properties (Millar et al., 2001; Sanchez and Holmgren, 2005) , and binding to specific receptors on the host cell membrane then toxin entry into host cells (Salimian et al., 2010) . In addition, LT facilitates the immunogenicity of STa and STb in vaccines immunization against bacterial infections (Norton et al., 2012) . Therefore, using STa or STb fusion at the C terminus of LTB subunits would generate quadruple or quintuple anti-ST fusion antigens . Thus, LT plays a key role in the prevention of enteric infection. Moreover, previous vaccines were mainly targeted at LT-STa or against LT-STb, so diarrhoea caused by enterotoxins (LTB, STa, STb) could not be completely prevented Ruan et al., 2014) , to prevent enterotoxin-induced diarrhoea in piglets, two vaccines need to be used simultaneously. In this study, increasing immunogenicity of enterotoxins (STa, STb) a mature STb peptide fused to a full-length of porcine STa A13Q toxoid generated STa 13 -STb fusion antigen. However, the preliminary results of this laboratory show that STa 13 can poison its own cells after four Fig. 7 . In vitro neutralization assays of samples from group ER-T neutralized to LT, STa and STb toxin. A-D. Serum, splenocyte lysate, intestinal mucus and mesenteric lymphocyte lysate from immunized mice showed neutralization efficiency to LT toxin when compared with that from control mice. E-H. Serum, splenocyte lysate, intestinal mucus and mesenteric lymphocyte lysate from immunized mice showed neutralization efficiency to STa toxin when compared with that from control mice. I-L. Serum, splenocyte lysate, intestinal mucus and mesenteric lymphocyte lysate from immunized mice showed neutralization efficiency to STb toxin when compared with that from control mice. The ratios on the figure are the dilution gradient of toxins, the immune mice produced antibodies that protected ZYM-DIEC02 cells (cell death < 50%), the control group did not protect ZYM-DIEC02 cells. regions of the GM1 receptor; we also retained GM1 binding activity as suggested. Data from this study indicated that ER-T expression fusion gene LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb elicits specific immune response anti-LT, anti-STa and anti-STb in a mouse model by the oral route. We chose the location of pseudogene yaiT gene, inserted by IS element, in addition far away from the promoter and terminator. Homologous recombination systems were used to insert exogenous genes on pseudogenes. Then, the influence on ER-T of biological activity and growth was tested (Echols et al., 2002; Balakirev and Ayala, 2003) .
IgA production exceeds all the other immunoglobulins at the mucosal surface. Thus, IgA plays a significant role in defending against the invasion of pathogens. Our results indicated faecal ER-T sIgA levels against LTA (day 21, P < 0.001), LTB (day 14, P < 0.001), STa (day 21, P < 0.05), STb (day 21, P < 0.01) and F41 (day 21, P < 0.01). Likewise, ELISA titres of IgG display statistically significant differences in spleens, milk, mesenteric lymph nodes and intestinal mucus of mice immunized with ER-T. In addition, serum IgG and faecal sIgA titres from mice after immunization with the vaccine ER-T were conspicuously higher than those of the control group in both experiments (P < 0.05). This indicates oral administration could trigger immune responses not only mucosa but also systemically. The lymphocyte proliferation assay indicated that SI ratios of splenocytes and mesenteric lymphocytes cell proliferative responses were significantly higher in the ER-T immunized groups than in controls (P < 0.05; Fig. 6 , panels A and B). For this study, within the ER-T groups of mice immunized by oral administration, results suggested that LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb fusion antigen can induce sufficient cellular immune responses. Immunized mice had higher levels of IL-4 than IFN-c. The IFN-c effects are partially blocked by IL-4 in infectious diseases (Myers et al., 1992) , suggesting that recombinant strains induced Th2-preferred responses. in vitro and in vivo neutralization assays were performed for evaluating the sufficient neutralizing antibody titres by ER-T. Results showed that after LT, STa and STb enterotoxin incubation with serum, splenocyte lysate, intestinal mucus and mesenteric lymphocyte lysate samples from the immunized mice had the capability of preventing infection of ZYM-DIEC02 cells in vitro. Furthermore, these samples obviously neutralized the biological activity for STa and STb enterotoxins in suckling mice.
Experimental procedures
Bacterial strains, plasmids and cells
The strains used in this study are listed in Table 1 . E. coli O142 was deposited in the Chinese Veterinary Culture Collection Center (Beijing, China) (CVCC accession no. C83920). E. coli C83903 was purchased from the Chinese Institute of Veterinary Drug Control (Beijing, China). Strain LT 192 -STa 13 fused LT 192 (GenBank accession no. CP002732.1) with (GenBank accession no. V00612.1) and Strain LT 192 -STb (GenBank accession no. AY028790.1) have been previously described (Liu et al., 2015a (Liu et al., ,2015b . The plasmids constructed and used are listed in Table 2 . Plasmids pDOC-K, pDOC-C and pACBSCE were kindly provided by Prof. David J. Lee (School of Biosciences, University of Birmingham, UK).
Construction and characterization of the double selection platform
A double selection platform was established using gene doctoring method and k-red method (Datsenko and Wanner, 2000; Lee et al., 2009) . Restructuring strategy flow chart of E. coli O142: MSTa double selection platform is displayed in the online Resource Fig. 1 , panel A. Briefly, use primer T1 paired with T2 to clone the left homologous arms from E. coli O142:DSTa, use primer T3 paired with T4 to clone the right homologous arms from E. coli O142:DSTa (the primers T1, T2, T3 and T4 are listed in Table 3 ), construct pKil-donor plasmid, insert the left fragment and right fragment into the pKil plasmid. Transform pACBSCE plasmid and pKil-donor plasmid into E. coli O142:DSTa, subsequently, homologous recombination is induced by L-arabinose, then generated O142 (yaiT-Kil) double selection platform. Use PCR primers (T1 and T4) to verify that pKil-donor fragment was assembled on the platform, the platform screening capability validation by 30 and 43°C, as previously described (Liu et al., 2015a (Liu et al., ,2015b .
Construction and characterization of the recombinant E. coli
Merges chimeric gene produced the LTA1-STa13-STb-LTA2-LTB-STa13-STb by splicing overlap extension (SOE) PCR (Fig. 2, panel A) . The first PCR, using LT 192 -STa 13 (constructed and preserved in our laboratory) as the template and primer P1 paired with P3, generated a fragment including the native LT gene promoter, full-length LT 192 genes and the 3 0 end of the STa 13 gene (26 bp). The second PCR, using P2 and P4 primer and LT 192 -STb (constructed and preserved in our laboratory) as the template, yield the fragment consisted of the 3 0 end of the STa 13 gene (13 bp), the STb, the 6 9 His gene and the native LT gene terminator. In the third step, we used a splicing overlap extension (SOE) PCR, connected the DNA fragment from the first and second PCR step and generated the fusion gene LT 192 -STa 13 -STb cassette. In the fourth PCR, we used LT 192 -STa 13 -STb as the template, primer P5 with P6, and generated STa A13Q -STb-6 9 His gene and A1 gene (1500 bp), named STa-STb-6 9 His. In the fifth PCR, we use the same template as in the fourth, primer P1 with P7, and generated A1 gene (1500 bp), named A1. In the sixth PCR by primer P1 paired with P8, we used STa-STb-6 9 His and A1 as the template, and generated the fragment consisting of the LT 192 A1 subunit and the STa A13Q -STb-6 9 His (1700 bp), named LTA1-STaSTb-6 9 His. In the seventh PCR, we used LT-STa 13 -STb as the template by primer P9 with P2, and generated a fragment including the LTA2 subunit, the LTB subunit and the STa 13 -STb-6 9 His chimeric gene, named A2-LTB-STa-STb-6 9 His. Subsequently, the eighth SOE PCR connected the LTA1-STa-STb-6 9 His and A2-LTB-STa-STb-6 9 His fragment and produced fusion genes (LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb cassette). The primers are listed in Table 4 . The LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb cassette was inserted into the pDOC-C plasmid by restriction endonucleases, producing the pL-S plasmid, employing left side and right side PCR products ligated into pL-S plasmid and generating yaiT(pL-S-Donor) plasmid respectively. Then, for pACBSCE plasmid, pL-S-Donor plasmid co-transformation selection platforms, an analogous protocol was used for homologous recombination as mentioned above, to yield the recombinant E. coli O142(yaiT:: LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb), named as ER-T (Fig. 2, panel B) . Recombinant E. coli strains were identified by PCR, using primers L-arm paired with P2 respectively. The primers are listed in Table 3 . The sequences of the respective fusion genes were confirmed by sequencing. Moreover, recombinant E. coli expressions of LTA1-STa 13 -STb-LTA2-LTB-STa 13 -STb fusion protein separated by 12% SDS-PAGE, examined with anti-His, were used as primary antibody and secondary antibody by (HRP)-conjugated goat anti-mouse IgG, as previously described (Liu et al., 2015a (Liu et al., ,2015b .
Feasibility analysis
Recombinant E. coli strains were further evaluated for feasibility as an oral vaccine by six different assays. First, the residual enterotoxicity in recombinant E. coli assay by suckling mouse and ZYM-DIEC02 cell. Briefly, 4-day-old suckling mice administered orally with Soybean trypsin inhibitor (2 mg ml À1 ; Solarbio, Beijing, China), and 100 ll of culture supernatant was inoculated intragastrically. The mice were killed after 4 h, G/C (the weight ratio of gut to the remaining carcass) ratios of ≥ 0.090 were confirmed positive for toxicity of STa or STb as previously described (Frantz and Robertson, 1981) . In the ZYM-DIEC02 cell assay, using 100 ll of culture supernatant incubation with ZYM-DIEC02 cells in 5% CO 2 at 37°C for 24 h, showed the change in the cells as previously described (Feng et al., 2013) . Second, we analysed the survival characteristics of recombinant E. coli in the simulation environment of the gastrointestinal tract. Briefly, recombinant E. coli was cultured in lysogeny broth (LB) medium, supplemented with gastric acid (1.5, 2.5, 3.5 or 4.5 of pH), and intestinal juice and bile (0.05%, 0.1%, 0.2%, 0.3% and 0.4%). After shaking at 37°C for 8 h, bacteria survival rate was determined by the plate method of enumerated intermittently, as previously described (Liu et al., 2015a (Liu et al., ,2015b . Third, we measured the influence of oral administration on feed intake and body weight. Briefly, groups of 10 six-week-old female BALB/c mice (Liaoning Changsheng Biotechnology Co., Ltd., China), received doses of 10 9 CFU, 10 10 CFU, 10 11 CFU and 10 12 CFU for 3 days, and were observed as previously described (You et al., 2011) . Fourth, the growth curves of the recombinant E. coli were determined. Briefly, isolate single clone of ER-T from LB agar medium then inoculate into LB medium, at intervals of 2 h, take sample from LB medium, use the plate method to produce growth curves, as previously described (Yang et al., 2015) . Growth curves of E. coli O142, O142: DSTa, ER-T. Fifth, analyse the structural stability of ER-T, continuous subcultures ER-T for 100 generations, then the 100 generations ER-T are plated on LB agar medium, randomly selected several colonies, and identified using PCR primers L-arm paired with P2, as described above (Nguyen et al., 2005) .Sixth, recombinant E. coli was examined via electron microscope (EM). Briefly, recombinant E. coli was in static culture for 3 days, placed onto Formvar carbon-coated copper grids (200 mesh), then stained with 2% potassiumphosphotungstic acid (pH 6.8) and observed by EM as previously described (Torres et al., 2004) . Seventh, recombinant E. coli intestinal colonization was evaluated. Briefly, six-week-old BALB/c mice were orally administered nalidixic acid-resistant (Nal) recombinant E. coli ER-T 10 9 CFU. Subsequently, faeces samples were collected at 7 day intervals and incubated on LB Nal agar plates, the assessed by PCR as described above (Huang et al., 2013) .
Oral immunization of mice
A total of 80 six-week-old BALB/c mice were split into eight groups (A, B, C, D, G1 female BALB/c mice, G2, G3 and G4 male BALB/c mice), with 10 mice per group. ER-T was grown in improved MINCA medium for 24 h at 37°C and harvested by centrifugation. Resuspension of ER-T centrifugal sedimentation in milk arrived at concentration of approximately 1 9 10 10 CFU ml À1 .
Mice in group A and B were orally administered with 10 9
CFUs of ER-T with a 1.5-inch, 20 gauge ball-tip needle. Mice in group C and D received 10 9 CFUs of O142: MSTa.
G1, G2, G3 and G4 as control groups received doses of 0.1 ml of milk. All groups were inoculated on a single day (Time 0); then, identical booster doses were administered on 14 and 28 days later. At 21 days, groups B coupled with G2, D coupled with G4, G1 coupled with G3, as previously described (Liu et al., 2015a (Liu et al., ,2015b .
ELISA analysis for antibody levels
IgG and IgA antibodies were measured by enzymelinked immunosorbent assay (ELISA). On days 0, 7, 14, 21, 28, 35 and 42, mice were killed and samples harvested as previously described . Briefly, the plates were coated with purified lymphotoxin alpha (LTA) recombinant protein, lymphotoxin beta (LTB) recombinant protein, F41 fimbriae, 4 9 STa recombinant protein and MBP-STb recombinant protein at 50, 50, 200, 100 and 200 ng per well, respectively, then treated samples with serial dilution with PBS as the primary antibodies. HRP-conjugated goat anti-mouse IgA (SigmaAldrich, St. Louis, MO, USA) or IgG (ZSGB-BIO Co., Beijing, China) were used for bound antibodies detection as previously described (Jiang et al., 2014) .
Lymphocyte proliferation assay and Cytokine assay
Forty-two days after the first immunization, mice mesenteric lymphocytes and splenic lymphocytes were collected and measured by MTT assay, as previously described (Liu et al., 2015b) . Briefly, the lymphocytes were incubated in 96-well plates at 5 9 10 5 lymphocytes cells/well for 100 ll then stimulated in vitro with LT (10 lg ml À1 ), STa (10 lg ml
À1
), STb (10 lg ml
), LT 192 -STa 13 (10 lg ml À1 ) proteins and LT 192 -STb (10 lg ml À1 ) proteins for 100 ll respectively. Meanwhile, concanavalin A (con A) (10 lg ml
) was used as a positive control and a black controls were without proteins. The plates were kept at 37°C in 5% CO 2 for 72 h and then pulsed with MTT (10 mg ml À1 ) per well for 4 h. The absorbance was measured with a spectrophotometer at 570 nm. The stimulation indices (SI) were calculated by the following formula: SI proliferation = ODsample /OD normal . Th1 cells produce IFN-c, and Th2 cells produce IL-4. We used mice cytokine ELISA-kits (IFN-c and IL-4 kits; JRDUN, Shanghai, China) following the manufacturer's instructions to investigate the role of IFN-c (Th1) and IL-4 (Th2) cytokines in the spleen of mice.
In vitro neutralization assays
We used ZYM-DIEC02 cell to assay the neutralizing ability of mice inoculated intragastrically with ER-T. Serum, intestinal mucus, splenocyte lysate and mesenteric lymphocyte lysate samples were collected from mice. Filter-sterilized supernatant of enterotoxins LT, STa, STb, then serial dilutions respectively. Further, incubated enterotoxins with equal volume of mice samples at 37°C for 2 h, after that toxin-antibody mixture was added to the ZYM-DIEC02 cells culture plate 0.1 ml per well. After 24 h, crystal violet staining was carried out and normal cells were counted, as previously described (Guan et al., 2015) .
In vivo neutralization test
To assess the neutralization activity of antibodies, we used suckling mice (suckling mice from G1 coupled with G3, aged 4 days). Serial dilutions of enterotoxins STa were mixed with samples (samples from immunization mice), as above. Suckling mice were administered orally with STa toxin-antibody mixture 0.1 ml per mice. The in vivo neutralization of STb: fist orally soybean trypsin inhibitor, then received equal volume of STb toxin-antibody mixture. The negative control used the samples from the control group and received equal volume of STa, STb toxin-antibody mixture respectively. Four hours after oral inoculation, the mice were killed and samples harested, as previously described (You et al., 2011) .
Challenge for maternal antibody in suckling mice
The protective efficacy evaluation of maternal antibody uses suckling mice with milk from pregnant mice. Briefly, four 4-day-old mice per group received serial dilutions enterotoxins (STa or STb) 100 ll. After 4 h, the animals were killed and the G/C ratio was calculated as previously described (Norton et al., 2012) .
Statistical analysis
The aim of this study was to estimate the recombinant E. coli ER-T, statistical analysis (ANOVA) was performed by SPSS version 19.0 (SPSS Statistics, Chicago, IL, USA) and Graphpad Prism 5.0 (Graphpad software, San Diego, CA, USA), and are represented by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001), P values of < 0.05 were considered to be statistically significant.
